key: cord-0993921-8pra3qay
authors: Duan, L.; Zhang, S.; Guo, M.; Zhou, E.; Fan, J.; Wang, X.; Wang, L.; Wu, F.; Jin, Y.
title: Epidemiological and clinical characteristics in patients with SARS-CoV-2 antibody negative probable COVID-19 in Wuhan
date: 2020-06-22
journal: nan
DOI: 10.1101/2020.06.18.20134619
sha: d7311def7e42d6429bc0b57278450871dc1b4925
doc_id: 993921
cord_uid: 8pra3qay

Abstract Background Patients with suspected COVID-19 might be admitted to hospital. We aimed to describe the characteristic of SARS-CoV-2 antibody negative probable COVID-19 patients and give some suggestions to manage suspected COVID-19 patients. Methods We analyzed 616 confirmed COVID-19 patients and 35 SARS-CoV-2 antibody negative probable COVID-19 patients who were admitted in Wuhan Union Hospital from February 13, 2020 to February 16, 2020. Telephone interviews were conducted and medical records were reviewed for epidemiological, clinical, laboratory and radiographic data. Results Of the 35 SARS-CoV-2 antibody negative probable COVID-19 patients, all of them had tested at least 3 times of nucleic acid, 3 were believed to be non-SARS-CoV-2 infection. Compared with confirmed patients, antibody negative probable patients were younger (P=0.017), exhibited similar symptoms and chest CT images, had higher lymphocyte count (P=0.004) and albumin level (P<0.001), showed lower lactate dehydrogenase level (P=0.011) and erythrocyte sedimentation rate (P<0.001). During hospitalization, all the 35 patients had contacted with confirmed COVID-19 patients, but all used general face mask for protection and maintained a social distance of more than one meter from each other. All the isolation wards were kept ventilation and disinfected once a day. After discharged from hospital, all of them had negative nucleic acid tests and no one developed symptoms again. Conclusions The conditions of patients with AbN probable COVID-19 were less critical than those of patients with confirmed COVID-19. Room ventilation and daily disinfection, wearing face masks, and maintaining social distance might be helpful to prevent patients from hospital acquired COVID-19 infection.

confirmed COVID-19 and antibody negative (AbN) probable COVID-19. And we want to offer some suggestions to managing AbN probable COVID-19 patients since some of them may not be COVID-19 infection.

This single-centre, retrospectivestudy (clinical trial identifier ChiCTR2000029770) was conducted at Wuhan Union Hospital (including two designated branch hospitals to treat patients with COVID-19).

College, Huazhong University of Science and Technology (20200036), the requirement for informed consent was exempted by the Ethics Committee.

The inclusion criteria were adult patients with confirmed and suspected COVID-19 on admission.

Patients with negative RT-PCR testing results but didn't test SARS-CoV-2 antibody were excluded.

From February 13 to February 16, 2020, 616 confirmed COVID-19 patients and 133 suspected COVID-19 patients were admitted in Wuhan Union Hospital. Of the 133 suspected patients, 98 didn't test SARS-CoV-2 antibody, 35 showed negative serological SARS-CoV-2 antibody results ( Figure   1 ).

The diagnosis was made and clinical classification of COVID-19 was performed for the patients according to the Guidelines of the Diagnosis and Treatment of New Coronavirus Pneumonia (version 7) published by the National Health Commission of China. 8 The diagnosis was established on the basis of (1) epidemiological history, (2) fever and/or other respiratory symptoms, (3) presence or . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 22, 2020. . https://doi.org/10.1101/2020.06.18.20134619 doi: medRxiv preprint absence of the imaging findings of novel coronavirus pneumonia, and (4) normal/reduced white blood cell count and normal/reduced lymphocyte count. A patient was taken as suspected case if she or he had epidemiological history, two of the aforementioned clinical presentations, or had no clear epidemiological history but had three of the clinical presentations. Suspected cases were considered to be confirmed if (1) real-time fluorescence RT-PCR for SARS-CoV-2 nucleic acid yielded positive results, or (2) Positive SARS-CoV-2 specific IgM and IgG antibody, or (3) Demonstration of a four-fold or greater increase in IgG antibody titer or conversion from a negative to a positive result between acute-and convalescent-phase serum specimens.

Medical records were also reviewed for detail demographic and clinical information. All discharged patients with suspected COVID-19 infection were interviewed by telephone to collect the updated SARS-CoV-2 nucleic acid and antibody results. AbN probable COVID-19 patients were further investigated by telephone interview to record their potential contact and exposure history before and after admitted to hospital.

Categorical variables were presented as frequency rates and percentages, and continuous variables were expressed as mean±standard deviation (SD) if they were normally distributed or median (interquartile range [IQR]) if they were not. Proportions for categorical variables were compared using the χ 2 test or Fisher's exact test. Means for continuous variables were compared using independent group t test when the data were normally distributed. Otherwise, the Wilcoxon rank-sum test was employed. Missing data have been mentioned in the relevant tables, and there was no other . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 22, 2020. . https://doi.org/10.1101/2020.06.18.20134619 doi: medRxiv preprint missing data, unless otherwise noted. All statistical analyses were performed by using SAS software package (version 9.4).

The demographic and clinical characteristics at admission for the 616 confirmed and the 35 AbN probable patients are listed in Table Table 2 shows the laboratory findings and chest CT scan on admission. Compared with confirmed patients, AbN probable patients showed higher lymphocyte count (P=0.004), CD8 lymphocytes proportion (P=0.024) and albumin level (P<0.001). The lactate dehydrogenase (LDH, P=0.011), . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 22, 2020. showed abnormal chest CT scan, 32 of them showed patchy or ground-glass opacity. During the course of the disease, 5 (14.3%) patients always showed unilateral lung involvement while 29 (82.9%) patients showed bilateral involvement. No significant differences were seen in chest CT scan between confirmed patients and AbN probable patients.

All the AbN probable patients had tested at least 3 times of nucleic acid, the median times of SARS-CoV-2 nucleic acid test was 6.0 (IQR, 4.0-8.0). Among the 35 AbN probable COVID-19 patients, the duration from symptoms onset to first antibody test was 50.0 (IQR, 24.0-72.0) days, 12 patients had their antibody test two or more times, 8 patients tested the antibodies in two or more places in different time (Table 1 ). Figure 2 shows the time lines of SARS-CoV-2 nucleic acid and antibody test in the 12 patients who tested antibody two or more times. Another 23 AbN probable COVID-19 patients who tested antibody only once ( Figure S1 ). During hospitalization, 20 of the AbN probable patients had tested serological mycoplasma and chlamydia antibodies, 15 of them showed positive mycoplasma or chlamydia IgG antibodies. Of the 35 AbN probable patients, a family cluster of 3 patients were admitted to the hospital and lived in one isolation ward. Table S1 shows the pathogens examined by the 3 patients. The 3 patients were eventually diagnosed as non-COVID-19 infection.

Of the 35 AbN probable COVID-19 patients, 14 had close contacted with confirmed or suspected COVID-19 patients before admission, 21 patients don't know whether they had contacted patients . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 22, 2020. . https://doi.org/10.1101/2020.06.18.20134619 doi: medRxiv preprint with COVID-19. All the 35 patients had contacted with confirmed patients in hospital (in fever outpatient clinics or isolation wards), 32 patients shared the same room with confirmed COVID-19 patients. During hospitalization, the 35 patients almost wore face mask all the time, even when sleeping. All the patients except the 3 index family members claimed that they had maintained a distance of more than one meter when contacting with other patients. Additional measures were also taken by hospital and health-care workers to prevent patients from hospital acquired infection: 1) All health-care workers should disinfect their hands before contact with another patient; 2) Maintaining ventilation; 3) Surface disinfection of isolation wards every day; 4) Air disinfection for at least 1 hour per day. After discharged from hospital, all of them had negative SARS-CoV-2 nucleic acid tests and no one developed symptoms again.

Our study compares the clinical features between patients with confirmed COVID-19 and those with AbN probable COVID-19. We found that, compared with features in patients with confirmed COVID-19, patients with AbN probable COVID-19 were younger, showed higher lymphocyte count, albumin level and had lower LDH and ESR level. Previous studies have shown older age, lower lymphocyte count and higher levels of LDH to be associated with severe COVID-19 at admission. [9] [10] Another study demonstrated that decreased albumin was independent risk factor which influence the improvement of COVID-19 patients. 11 Therefore, the conditions of patients with AbN probable COVID-19 were less critical than those patients with confirmed COVID-19. However, no significant differences were seen in any symptoms and chest CT findings between confirmed and AbN probable patients, suggesting that it's hard for physicians to distinguish confirmed and AbN probable COVID-19 patients on admission.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 22, 2020. . https://doi.org/10.1101/2020.06.18.20134619 doi: medRxiv preprint Several reasons might contribute to the negative antibody test in the 35 patients: 1) false negative results of antibody test; 2) the delay of SARS-CoV-2 antibody production; 3) some of the them were conventional infection rather than COVID-19 infection. A study in our hospital showed the sensitivity of IgM and IgG test in suspected COVID-19 patients were 87.5% and 70.8%, respectively. 12 A study in Italy even showed that IgG had 100% sensitivity on day 12 from symptoms onset. 13 Two independent studies also demonstrated that on day 19 and day 15, the SARS-CoV-2 antibody could be tested on all the confirmed COVID-19 patients. 14 Our study had several limitations. First, this is a retrospective study and there is no definite evidence that the AbN probable patients were infected with other pathogens. Second, not all suspected COVID-19 patients had tested SARS-CoV-2 antibody, those patients were excluded from our study and may cause selection bias. Third, no exposure control could be founded for the 35 AbN probable COVID-19 patients, we could not determine which measure are useful to protect patients from hospital acquired COVID-19 infection.

Our study demonstrated that the conditions of patients with AbN probable COVID-19 were less critical than those of patients with confirmed COVID-19. But in fact, we cannot distinguish without SARS-CoV-2 infection from suspected COVID in clinical practice. We firstly points out the realistic dilemma about managing patients with suspected COVID-19: some patients without SARS-CoV-2 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 22, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 22, 2020. . https://doi.org/10.1101/2020.06.18.20134619 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 22, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 22, 2020. . https://doi.org/10.1101/2020.06.18.20134619 doi: medRxiv preprint Table 3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 22, 2020. . https://doi.org/10.1101/2020.06.18.20134619 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 22, 2020. . https://doi.org/10.1101/2020.06.18.20134619 doi: medRxiv preprint

A new coronavirus associated with human respiratory disease in China

A Novel Coronavirus from Patients with Pneumonia in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

Analytical Performances of a Chemiluminescence Immunoassay for SARS-CoV-2 IgM/IgG and Antibody Kinetics

Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease

People With Suspected COVID-19 Symptoms Were More Likely Depressed and Had Lower Health-Related Quality of Life: The Potential Benefit of Health Literacy